{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Dosages for treatment with anti-ErbB2 antibodies", "item": "https://www.patentleaderboard.com/patent/6627196"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Dosages for treatment with anti-ErbB2 antibodies

Dosages for treatment with anti-ErbB2 antibodies

US Patent 6627196 · Granted Sep 30, 2003

Estimated economic value: $566,731,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method to use gene expression to determine likelihood of clinical outcome of ren2025
Method to use gene expression to determine likelihood of clinical outcome of ren2023
Gene expression profile algorithm for calculating a recurrence score for a patie2023
Gene expression markers for breast cancer prognosis2022
Gene expression profile algorithm and test for determining prognosis of prostate2021
Method to use gene expression to determine likelihood of clinical outcome of ren2021
Prediction of likelihood of cancer recurrence2020
Treatment with anti-ErbB2 antibodies2019
Treatment with anti-ErbB2 antibodies2019
Method for using gene expression to determine prognosis of prostate cancer2019
Gene expression profile algorithm and test for likelihood of recurrence of color2019
Gene expression profile algorithm for calculating a recurrence score for a patie2019